Commission Implementing Decision of 26 April 2011 allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134 (notified under document C(2011) 2668) (Text with EEA relevance) (2011/252/EU) (revoked)
EU Decision 2011/252 · Adopted 26 April 2011 · Extends to United Kingdom
Commission Implementing Decision
of 26 April 2011
allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134
(notified under document C(2011) 2668)
(Text with EEA relevance)
(2011/252/EU) (revoked)
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations to the whole text
Textual amendments
- F1
Decision revoked (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), reg. 1(1), Sch. 2 Pt. 2 (with reg. 29(2)) (as amended by S.I. 2020/1376, regs. 1(4), 3(20)); 2020 c. 1, Sch. 5 para. 1(1)
Contents
- 1Article 1 Repealed
- 2Article 2 Repealed
- 3Article 3 Repealed